1-1 of 1
Velusamy Muthusamy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase III, multicenter, randomized, placebo controlled, double-blind study to assess efficacy and safety of crizanlizumab (5 mg/kg) versus placebo, with or without hydroxyurea/hydroxycarbamide therapy, in adolescent and adult sickle cell disease patients with frequent vaso-occlusive crises: The sparkle study

Free
Andrew Campbell, Ana Silva-Pinto, Obiageli Nnodu, Deepa Manwani, Deborah Keefe, Jimmy Watson, Evgeniya Reshetnyak, Velusamy Muthusamy, Partha Banerjee, Olufolake Egbujo (Adisa), Michele Nassin, Yvonne Dei-Adomakoh
Journal: Blood
Blood (2025) 146 (Supplement 1): 1198.
https://doi.org/10.1182/blood-2025-1198
Published: 2025